Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Corporate & Other — Operating Revenue by Quarter
Corporate & Other — Operating Revenue ($M)
Elevance Health Corporate & Other — Operating Revenue: $6M in Q3 2026, down 96.0% from a year earlier.
Latest, Q3 2026
6
Period ended Sep 30, 2026
Change on a year earlier
-96.0%
149 in Q3 2025
History
20 quarters
Since Q4 2021
Sources
16
Documents cited below
Where the Q3 2026 figure comes from
“|| Corporate & Other | 6 | 149 | (96.0) | % | 16 | 546 | (97.1) | %”
Source: 8-K ER (FY2026Q3, 2026-10-21) ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Elevance Health Corporate & Other — Operating Revenue ($M), quarterly Q4 2021–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg-rev-corporate-other
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.